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Introduction: Abdominal aortic aneurysm (AAA) is the most
common form of aortic aneurysm and is deﬁned as a dila-
tion of the diameter of the aorta by at least 50%. It is a
major and rising cause of mortality in the Western world in
elderly people. The immune system has been implicated, in
part, in the pathogenesis of this condition and we therefore
aimed to investigate whether individuals with immune-
mediated diseases have an increased risk of subsequent
AAA.
Methods: We carried out a record-linkage study analysing
datasets of linked hospital admissions and death registra-
tions for the whole of England from January 1999 to
December 2011. Rate ratios for AAA were calculated by
comparing the occurrence of AAA in people with and
without immune-mediated diseases.
Results: We found a signiﬁcantly increased risk of AAA
following hospital admission or day case care for the
following immune-mediated diseases: asthma, autoim-
mune haemolytic anaemia, chronic active hepatitis,
Crohn’s disease, dermatomyositis, idiopathic thrombocy-
topenic purpura, multiple sclerosis, myxoedema, perni-
cious anaemia, primary biliary cirrhosis, psoriasis,
rheumatoidarthritis, scleroderma, Sjogren’s syndrome,
systemic lupus erythematosus (SLE), thyrotoxicosis and
ulcerative colitis. Rate ratios of two or greater were found
for SLE (rate ratio (RR) ¼ 2.84, 95% conﬁdence interval
(95%CI) 2.36e3.39, p < 0.001), chronic active hepatitis
(RR ¼ 2.48, 1.75e3.42, p < 0.001), dermatomyositis (RR
¼ 2.20, 1.24e3.65, p ¼ 0.003), asthma (RR ¼ 2.05, 1.79e
2.35, p < 0.001) and primary biliary cirrhosis (RR ¼ 2.28,
1.80e2.85, p < 0.001). When we split the outcomes into
AAA with and without mention of rupture, there were no
signiﬁcant differences in the RR for 26 of the 27 immune-
mediated diseases studied. There was nonetheless an
overall trend of higher RRs for unruptured than ruptured
AAA, suggesting that ruptured AAA may be an underesti-
mate of AAA in these cohorts due to some surveillance
bias and subsequent increased detection (and treatment)
of AAA prior to rupture.
Conclusion: Our study suggests an increased risk of subse-
quent AAA in individuals admitted to hospital with some
immune-mediated diseases.
Further work is needed to conﬁrm or refute our ﬁnd-
ings, but, if conﬁrmed, where the risk is particularly
elevated physicians should be mindful of this and of thepossible merits of offering screening for AAA to such
people.
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Introduction: Abdominal aortic aneurysm (AAA) is an aortic
dilatative affection, with high mortality risk associated with
wall rupture. Inﬂammatory process and extracellular matrix
degradation by metalloproteinases (MMPs) are involved in
AAA pathogenesis. Recently, a niche of mesenchymal stro-
mal cells (MSCs) with stemness properties and immuno-
modulatory ability has been discovered in different vascular
segments of healthy donors. The aim of the present study
was to verify the presence of mesenchymal progenitors also
in the aneurysmal tissue and investigate their role in AAA
pathogenesis.
Methods: Vascular tissues from AAA patients (n ¼ 15
males, mean age ¼ 66,1 years) were digested in an enzy-
matic solution. The cell population obtained was expanded
in vitro and analyzed for stemness markers (Nanog, Oct-4,
Sox-2) by RT-PCR. mRNA levels of AAA mediators (MMP2,
MMP9) were quantiﬁed using Real Time PCR in MSCs iso-
lated from aneurysm (AAA MSCs). MSCs derived from
thoracic aorta of healthy donors (hMSCs) were used as
controls. mRNA levels of anti-inﬂammatory cytokines IL-10
and HLA-G were detected in AAA and healthy MSCs to
investigate their immunomodulatory ability; co-culture of
activated peripheral blood mononuclear cells (MNCs) and
MSCs from aneurysm and healthy tissues was assessed to
verify MSCs inhibitory action on MNCs proliferation by
BromoDeoxyUridine incorporation assay. We tested the in
vitro effect of soluble IL-10 added to AAA MSCs to explore a
potential strategy of MMP9 modulation.
Results: MSCs successfully isolated from the aneurysmal
tissues expressed the stemness markers, as demonstrated
by RT-PCR. AAA MSCs showed MMP2 mRNA levels similar
to the control group, while MMP9 mRNA levels resulted
400-fold higher than controls. Immunoblotting conﬁrmed
MMP-9 increase in AAA patients. Compared to hMSCs,
AAA MSCs did not express HLA-G and exerted a less
immunosuppressive effect on MNCs proliferation (mean
BrdU incorporation 1.74  0.09 vs 2.41  0.19; p value
¼ 0.03, t test). IL-10 transcriptional levels were lower in
690 AbstractsAAA MSCs than hMSCs; after 24 h exposure of AAA MSCs
to IL-10 (10 ng/ml), we found a decrease of MMP9
mRNA production (60% lower compared to untreated
control).
Conclusion: Vascular wall-MSCs with stemness properties
can assume a pathological phenotype, as demonstrated by
the loss of immunomodulatory ability and the increased
expression of MMP9, involved in AAA progression.
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Introduction: Over the last decade, interventional endo-
vascular stenting of aortic aneurysm has been developed
from single center experiences to a standard procedure in
many countries. One integral part for the success of this
minimally-invasive procedure is innovative and improved
vascular imaging. One of the most difﬁculty in learning and
performing this interventional therapy is the fact, that the
three-dimensional vascular tree has to be overlain with the
two-dimensional angiographic scene by the vascular
surgeon.
Methods: We report the development of real-time navi-
gation software, which allows a three-dimensional endolu-
minal view of the vascular system during an EVAR-
procedure in patients with infrarenal aortic aneurysm. Even
in patients with complex anatomy, the surgeon or the
interventionalist achieves an accurate option of spatial
perception concerning the current vascular anatomy, e.g.
the position of the guide-wire.
We analyzed patients with an infra-renal aortic aneu-
rysm in which the planning CT-Scans were volume-
rendered. At the beginning of the intervention the rele-
vant landmarks were matched in real-time with the two-
dimensional angiographic scene. During intervention the
software continuously registers the position of the guide-
wire or the stent. An additional 3d-screen shows the
generated endoluminal view during the whole interven-
tion in real-time.
Results: Our preliminary results of navigated endoluminal
virtual angioscopy are promising. The “Virtual angioscope”
may improve intraoperative visualization, placement of
guide-wires and stents. It may reduce the amount of
contrast agents and exposure to x-Rays. The prototype also
offers the possibility of intervention planning and simula-
tion which may lead to a reduced learning curve and
therefore patient safety.
Conclusion: Not only for pre-interventional simulation, even
in training of inexperienced surgeons or interventionalists,
our 3D navigation system may offer better visualization in
complex endoluminal aortic procedures.Plasma and Patterning: The New Focus for the Development of
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Introduction: The concept of surface modulation holds
much promise for the future development of vascular
grafts. Our aim is to enhance a nanocomposite material
using surface modiﬁcation techniques such as plasma
technology and surface patterning to augment both surface
chemistry and topography with a view towards
endothelialisation.
Methods: Polyhedral oligomeric silsesquioxane (POSS)
was combined with polycarbonate urea urethane (PCU) to
produce a Nanocomposite polymer. Microgrooves with
pitch size of 25 mm was created using photolithography.
Fidelity was veriﬁed with scanning electron microscopy
(SEM) and atomic force microscopy (AFM). The polymer
was then exposed to pure O2 plasma and contact angles
were measured. Human umbilical vein endothelial cells
(HUVECs) were then seeded onto POSS-PCU. The meta-
bolic activity of the cells was assessed and immuno-
staining was used and subsequently visualised with
confocal microscopy.
Results: Contact angle results (mean: 85) show the increase
hydrophilicity of the polymer surface and both AFM and SEM
conﬁrm the high replication of the microgrooves within the
surface of the polymer using photolithography. Metabolic
activity of HUVECs on the surface modiﬁed polymer was
signiﬁcantly increased compared with control (p < 0.05).
Further immunostaining further conﬁrms the adhesive na-
ture of the cells as well as the migratory potential.
Conclusion: Using a combination of plasma technology and
surface patterning to augment both surface chemistry and
topography on a nanocomposite polymer promotes
increased endothelial cell adhesion, migration and prolif-
eration. The ordered microgrooves were seen to enhance
cellular adhesion and spreading. Plasma technology and
micro-grooving is a promising methodology to optimise
luminal endothelisation and the prospect for ‘self-endo-
thelisation.’
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Introduction: Therapeutic augmentation of collateral artery
sprout and growth (i.e., angiogenesis and arteriogenesis) is
of particular clinical interest in improving blood ﬂow in
vascular occlusive disease. We found that low doses of
